Year: 2018
Type: editorial
Abstract: The report by Mokdad and colleagues in this issue of Cancer addresses an increasingly important concern in the conduct of early phase oncology clinical trials. Here, the advantages and caveats of their proposed approach are discussed. See referenced original article on pages 3339‐45 , this issue.
Source: Cancer
DOI: 10.1002/cncr.31574
Authors: Suzanne E. Dahlberg, Robert J. Gray
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: bronze
Funder: National Cancer Institute
OpenAlex ID: W2818300374